Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Bristol-Myers Squibb names new chief scientific officer

Bristol-Myers Squibb names new chief scientific officer

15th March 2017

Bristol-Myers Squibb has announced the appointment of Dr Thomas Lynch as its new executive vice-president and chief scientific officer, effective as of March 16th.

Dr Lynch will bring more than 30 years of medical, management and leadership experience to the company, with around 23 of these years spent working at Massachusetts General Hospital.

He served as chairman and chief executive officer of Massachusetts General Physicians Organization and as a member of the hospital's board from 2015 to 2017, and was part of the team credited with the discovery that certain genetic mutations in lung cancer patients affect the efficacy of specific treatments.

This expertise will be particularly pertinent to his work with Bristol-Myers Squibb, as targeted therapies and personalised medicine are an emerging area of focus for the company.

Dr Lynch will succeed Dr Francis Cuss, who is retiring from the company, although he has agreed to serve as an advisor for the next three months to ensure a seamless transition.

Dr Giovanni Caforio, chief executive officer and chairman designate of Bristol-Myers Squibb, said: "With deep experience as a clinical researcher, leader of large research centres and a practicing physician, Tom brings unique, important and timely perspectives to the business."

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.ADNFCR-8000103-ID-801833573-ADNFCR

We currently have 8 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.